Technologies

iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology

  • by

​  Robot Bacteriophage against microbiome associated with colorectal cancer Bacteriophage Improvement Platform technology with a broad antimicrobial activity Proprietary Technology incorporating CRISPR/Cas Technology BOSTON, Feb. 15, 2024 /PRNewswire/ — iNtRON Biotechnology (“iNtRON”, www.intodeworld.com) has announced… Read More »iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology